Jill A. Howe - 14 Nov 2022 Form 3 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role: Chief Financial Officer
Signature: /s/ Grant Harbert, as Attorney-in-Fact
Issuer symbol: LCTX
Transactions as of: 14 Nov 2022
Net transactions value: $0
Form type: 3
Filing time: 16 Nov 2022, 15:15:20 UTC
Previous filing: 17 Jun 2022
Next filing: 05 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney